These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 38117688)
1. Exploiting the Carboxylate-Binding Pocket of β-Lactamase Enzymes Using a Focused DNA-Encoded Chemical Library. Park S; Fan J; Chamakuri S; Palaniappan M; Sharma K; Qin X; Wang J; Tan Z; Judge A; Hu L; Sankaran B; Li F; Prasad BVV; Matzuk MM; Palzkill T J Med Chem; 2024 Jan; 67(1):620-642. PubMed ID: 38117688 [TBL] [Abstract][Full Text] [Related]
4. Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach. Muteeb G; Alsultan A; Farhan M; Aatif M Molecules; 2022 Feb; 27(4):. PubMed ID: 35209073 [TBL] [Abstract][Full Text] [Related]
5. Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D). Romero E; Oueslati S; Benchekroun M; D'Hollander ACA; Ventre S; Vijayakumar K; Minard C; Exilie C; Tlili L; Retailleau P; Zavala A; Elisée E; Selwa E; Nguyen LA; Pruvost A; Naas T; Iorga BI; Dodd RH; Cariou K Eur J Med Chem; 2021 Jul; 219():113418. PubMed ID: 33862516 [TBL] [Abstract][Full Text] [Related]
6. Progress toward inhibitors of metallo-β-lactamases. McGeary RP; Tan DT; Schenk G Future Med Chem; 2017 May; 9(7):673-691. PubMed ID: 28504895 [TBL] [Abstract][Full Text] [Related]
7. Phenotypic and Moreira JS; Galvão DS; Xavier CFC; Cunha S; Pita SSDR; Reis JN; Freitas HF J Biomol Struct Dyn; 2022; 40(24):14223-14235. PubMed ID: 34766882 [TBL] [Abstract][Full Text] [Related]
9. Metallo-β-lactamase inhibitors: A continuing challenge for combating antibiotic resistance. Kang SJ; Kim DH; Lee BJ Biophys Chem; 2024 Jun; 309():107228. PubMed ID: 38552402 [TBL] [Abstract][Full Text] [Related]
10. Identifying Oxacillinase-48 Carbapenemase Inhibitors Using DNA-Encoded Chemical Libraries. Taylor DM; Anglin J; Park S; Ucisik MN; Faver JC; Simmons N; Jin Z; Palaniappan M; Nyshadham P; Li F; Campbell J; Hu L; Sankaran B; Prasad BVV; Huang H; Matzuk MM; Palzkill T ACS Infect Dis; 2020 May; 6(5):1214-1227. PubMed ID: 32182432 [TBL] [Abstract][Full Text] [Related]
11. OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam 'enhancer'. Morinaka A; Tsutsumi Y; Yamada M; Suzuki K; Watanabe T; Abe T; Furuuchi T; Inamura S; Sakamaki Y; Mitsuhashi N; Ida T; Livermore DM J Antimicrob Chemother; 2015 Oct; 70(10):2779-86. PubMed ID: 26089439 [TBL] [Abstract][Full Text] [Related]
12. Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design. Linciano P; Cendron L; Gianquinto E; Spyrakis F; Tondi D ACS Infect Dis; 2019 Jan; 5(1):9-34. PubMed ID: 30421910 [TBL] [Abstract][Full Text] [Related]
13. 1,4,7-Triazacyclononane Restores the Activity of β-Lactam Antibiotics against Metallo-β-Lactamase-Producing Somboro AM; Amoako DG; Osei Sekyere J; Kumalo HM; Khan R; Bester LA; Essack SY Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30478231 [TBL] [Abstract][Full Text] [Related]
14. Metallo-β-Lactamase Inhibitors Inspired on Snapshots from the Catalytic Mechanism. Palacios AR; Rossi MA; Mahler GS; Vila AJ Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32503337 [TBL] [Abstract][Full Text] [Related]
15. Structural and biochemical analysis of the metallo-β-lactamase L1 from emerging pathogen Stenotrophomonas maltophilia revealed the subtle but distinct di-metal scaffold for catalytic activity. Kim Y; Maltseva N; Wilamowski M; Tesar C; Endres M; Joachimiak A Protein Sci; 2020 Mar; 29(3):723-743. PubMed ID: 31846104 [TBL] [Abstract][Full Text] [Related]
16. β-Lactamases: A Focus on Current Challenges. Bonomo RA Cold Spring Harb Perspect Med; 2017 Jan; 7(1):. PubMed ID: 27742735 [TBL] [Abstract][Full Text] [Related]
17. In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant Peters BK; Reddy N; Shungube M; Girdhari L; Baijnath S; Mdanda S; Chetty L; Ntombela T; Arumugam T; Bester LA; Singh SD; Chuturgoon A; Arvidsson PI; Maguire GEM; Kruger HG; Naicker T; Govender T ACS Infect Dis; 2023 Mar; 9(3):486-496. PubMed ID: 36786013 [TBL] [Abstract][Full Text] [Related]
18. Penicillin sulfone inhibitors of class D beta-lactamases. Drawz SM; Bethel CR; Doppalapudi VR; Sheri A; Pagadala SR; Hujer AM; Skalweit MJ; Anderson VE; Chen SG; Buynak JD; Bonomo RA Antimicrob Agents Chemother; 2010 Apr; 54(4):1414-24. PubMed ID: 20086146 [TBL] [Abstract][Full Text] [Related]
19. Broad-Spectrum Inhibitors against Class A, B, and C Type β-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization. Farhat N; Gupta D; Ali A; Kumar Y; Akhtar F; Kulanthaivel S; Mishra P; Khan F; Khan AU Microbiol Spectr; 2022 Oct; 10(5):e0045022. PubMed ID: 36069578 [TBL] [Abstract][Full Text] [Related]
20. Structure-guided optimization of D-captopril for discovery of potent NDM-1 inhibitors. Ma G; Wang S; Wu K; Zhang W; Ahmad A; Hao Q; Lei X; Zhang H Bioorg Med Chem; 2021 Jan; 29():115902. PubMed ID: 33302045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]